Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report

Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report

Abstract Background The incidence of gemcitabine-induced hemolytic uremic syndrome has already been described in adults. Several approaches have been employed in the treatment of gemcitabine-induced hemolytic uremic syndrome with different outcomes. One of the most promising agents is eculizumab, wh...

Full description

Bibliographic Details
Main Authors: Ludovica Facchini, Maurizio Lucchesi, Alessia Stival, Rosa Maria Roperto, Francesca Melosi, Marco Materassi, Silvia Farina, Veronica Tintori, Maurizio de Martino, Iacopo Sardi
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Journal of Medical Case Reports
Subjects:
Microangiopathy
Eculizumab
Gemcitabine
Medulloblastoma
Radiotherapy
Brain tumors
Online Access:http://link.springer.com/article/10.1186/s13256-017-1373-5

Internet

http://link.springer.com/article/10.1186/s13256-017-1373-5

Similar Items